CRAPARO, Emanuela Fabiola
 Distribuzione geografica
Continente #
NA - Nord America 8.100
EU - Europa 3.917
AS - Asia 2.283
SA - Sud America 453
AF - Africa 108
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.878
Nazione #
US - Stati Uniti d'America 8.046
IT - Italia 1.173
CN - Cina 958
FI - Finlandia 721
UA - Ucraina 649
SG - Singapore 628
BR - Brasile 398
HK - Hong Kong 381
DE - Germania 341
IE - Irlanda 315
GB - Regno Unito 175
SE - Svezia 130
RU - Federazione Russa 122
FR - Francia 96
CI - Costa d'Avorio 70
IN - India 65
BE - Belgio 51
KR - Corea 50
TR - Turchia 35
CA - Canada 27
NL - Olanda 26
IQ - Iraq 24
VN - Vietnam 24
RO - Romania 23
ES - Italia 21
MX - Messico 21
BD - Bangladesh 20
AR - Argentina 18
AT - Austria 17
UZ - Uzbekistan 17
PL - Polonia 13
AU - Australia 10
IR - Iran 10
CH - Svizzera 9
SA - Arabia Saudita 9
CO - Colombia 8
JP - Giappone 8
MA - Marocco 8
PK - Pakistan 8
VE - Venezuela 8
EG - Egitto 7
KE - Kenya 7
EC - Ecuador 6
EU - Europa 6
LT - Lituania 6
MY - Malesia 6
AL - Albania 5
CZ - Repubblica Ceca 5
PY - Paraguay 5
ZA - Sudafrica 5
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
KG - Kirghizistan 4
LB - Libano 4
PE - Perù 4
TN - Tunisia 4
TW - Taiwan 4
BH - Bahrain 3
BO - Bolivia 3
LV - Lettonia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BG - Bulgaria 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ML - Mali 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 14.878
Città #
Fairfield 964
Ashburn 728
Chandler 627
Woodbridge 619
Ann Arbor 543
Houston 522
Wilmington 468
Singapore 406
Seattle 396
Hong Kong 374
Jacksonville 351
Cambridge 346
Dublin 314
Palermo 288
Medford 246
Nanjing 169
Princeton 152
Des Moines 135
Dearborn 126
Tulsa 97
Boardman 85
Altamura 80
Jinan 73
Lawrence 72
Abidjan 70
Beijing 70
Shenyang 65
San Diego 64
Hefei 62
Nanchang 61
New York 57
Hebei 51
Brussels 49
Changsha 47
Jiaxing 46
Milan 44
Seongnam 42
Tianjin 41
Santa Clara 40
Hangzhou 37
Ludwigshafen am Rhein 37
Ningbo 37
Saint Petersburg 33
Los Angeles 31
São Paulo 31
Redwood City 29
Düsseldorf 28
London 25
Zhengzhou 25
Lanzhou 24
Izmir 23
Verona 21
Guangzhou 20
Munich 18
San Paolo di Civitate 18
Washington 18
Council Bluffs 17
Frankfurt am Main 17
The Dalles 17
Belo Horizonte 16
Taiyuan 16
Helsinki 15
Rome 15
Brooklyn 14
Columbus 14
Moscow 13
Auburn Hills 12
Haikou 12
Kumar 12
Taizhou 12
Catania 11
Chicago 11
Fuzhou 11
San Mateo 11
Tashkent 11
Toronto 11
Campinas 10
Kunming 10
Norwalk 10
Phoenix 10
Pune 10
Baghdad 9
Bexley 9
Dallas 9
Ho Chi Minh City 9
Rio de Janeiro 9
Bari 8
Falkenstein 8
Hyderabad 8
Orange 8
Redmond 8
Turin 8
Turku 8
Aci Castello 7
Curitiba 7
Hanoi 7
Messina 7
Nairobi 7
Padova 7
Atlanta 6
Totale 9.912
Nome #
Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity Studies 191
Galactosylated polymeric carriers for liver targeting of sorafenib 185
Inulin Derivatives Obtained Via Enhanced Microwave Synthesis for Nucleic Acid Based Drug Delivery 174
Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells 170
UV-PHOTOCROSSLINKING OF INULIN DERIVATIVES TO PRODUCE HYDROGELS FOR DRUG DELIVERY APPLICATION 169
EMPLOYMENT OF CATIONIC SOLID-LIPID NANOPARTICLES AS RNA CARRIERS. 168
Biocompatible Lipid Nanoparticles as Carriers to Improve Curcumin Efficacy in Ovarian Cancer Treatment 162
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 159
KINETICS OF DIFFERENT PROCESSES IN HUMAN INSULIN AMYLOID FORMATION 156
PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions 156
pH-sensitive hydrogel based on a polyaspartamide derivative 155
Polymeric nanoparticles for siRNA delivery: Production and applications 155
COMPOSITE NANOPARTICLES BASED ON HYALURONIC ACID CHEMICALLY CROSS-LINKED WITH α,β-POLYASPARTYLHYDRAZIDE 154
HYDROGELS FOR POTENTIAL COLON DRUG RELEASE BY THIOL-ENE CONJUGATE ADDITION OF A NEW INULIN DERIVATIVE 151
BRAIN-TARGETED SOLID LIPID NANOPARTICLES CONTAINING RILUZOLE: PREPARATION, CHARACTERIZATION AND BIODISTRIBUTION 149
PHOSPHOLIPID-POLYASPARTAMIDE MICELLES FOR PULMONARY DELIVERY OF CORTICOSTEROIDS 149
Galactosylated Micelles for a Ribavirin Prodrug Targeting to Hepatocytes 148
Polyaspartamide-based nanoparticles loaded with fluticasone propionate and the in vitro evaluation towards cigarette smoke effects 148
PREPARATION OF POLYMERIC NANOPARTICLES BY PHOTO-CROSSLINKING OF AN ACRYLOYLATED POLYASPARTAMIDE IN W/O MICROEMULSION 146
AMPHIPHILIC POLY(HYDROXYETHYLASPARTAMIDE) DERIVATIVE-BASED MICELLES AS DRUG DELIVERY SYSTEMS FOR FERULIC ACID 146
PEGYLATED POLYASPARTAMIDE–POLYLACTIDE BASED NANOPARTICLES PENETRATING CYSTIC FIBROSIS ARTIFICIAL MUCUS 144
BIOCOMPATIBLE MICELLES BASED ON SQUALENE PORTIONS LINKED TO PEGYLATED POLYASPARTAMIDE AS POTENTIAL COLLOIDAL DRUG CARRIERS 143
PEGYLATED NANOPARTICLES BASED ON A POLYASPARTAMIDE. PREPARATION, PHYSICO-CHEMICAL CHARACTERIZATION, AND INTRACELLULAR UPTAKE 140
CROSSLINKED HYALURONAN WITH A PROTEIN-LIKE POLYMER: NOVEL BIORESORBABLE FILMS FOR BIOMEDICAL APPLICATIONS 138
KINETICS OF INSULIN AGGREGATION: DISENTANGLEMENT OF AMYLOID FIBRILLATION FROM LARGE-SIZE CLUSTER FORMATION 135
CURCUMIN ENTRAPPED INTO LIPID NANOSYSTEMS INHIBITS NEUROBLASTOMA CANCER CELL GROWTH AND ACTIVATES HSP70 PROTEIN 134
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis 134
Phea-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs 132
SOLID LIPID NANOPARTICLES CONTAINING NIMESULIDE: PREPARATION, CHARACTERIZATION AND CYTOTOXICITY STUDIES 131
LIPID NANOPARTICLES FOR DRUG TARGETING TO THE BRAIN 131
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases 130
FERULIC ACID-LOADED LIPID NANOSTRUCTURES AS DRUG DELIVERY SYSTEMS FOR ALZHEIMER’S DISEASE: PREPARATION, CHARACTERIZATION AND CYTOTOXICITY STUDIES 128
NOVEL CATIONIC SOLID-LIPID NANOPARTICLES AS NON-VIRAL VECTORS FOR GENE DELIVERY 127
LIPID NANOPARTICLES AS DELIVERY VEHICLES FOR THE PARIETARIA JUDAICA MAJOR ALLERGEN PAR J 2 126
Hepatocyte-targeted fluorescent nanoparticles based on a polyaspartamide for potential theranostic applications 126
EMPLOYMENT OF CATIONIC SOLID-LIPID NANOPARTICLES AS RNA CARRIERS 125
Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells 124
IN VITRO BIOLOGICAL EVALUATION OF FOLATE-FUNCTIONALIZED BLOCK COPOLYMER MICELLES FOR SELECTIVE ANTI-CANCER DRUG DELIVERY 123
LIPID NANOCARRIERS CONTAINING ESTER PRODRUGS OF FLURBIPROFEN. PREPARATION, PHYSICAL-CHEMICAL CHARACTERIZATION AND BIOLOGICAL STUDIES 123
POLYASPARTAMIDE-POLYLACTIDE GRAFT COPOLYMERS WITH TUNABLE PROPERTIES FOR THE REALIZATION OF FLUORESCENT NANOPARTICLES FOR IMAGING 123
NANOPARTICULATE SYSTEMS FOR DRUG DELIVERY AND TARGETING TO THE CENTRAL NERVOUS SYSTEM 122
Margination of fluorescent polylactic acid-polyaspartamide based nanoparticles in microcapillaries in vitro: The effect of hematocrit and pressure 122
Cationic solid-lipid nanoparticles as vector for RNA delivery 121
Gold nanostar-polymer hybrids for siRNA delivery: Polymer design towards colloidal stability and in vitro studies on breast cancer cells 121
PEGYLATED PHOSPHOLIPID-POLYASPARTAMIDE COPOLYMERS AS SELF-ASSEMBLING COLLOIDAL DRUG DELIVERY SYSTEMS 120
Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate 120
NANOPARTICLES BASED ON NOVEL AMPHIPHILIC POLYASPARTAMIDE COPOLYMERS 119
Silibilina per il trattamento delle patologie oculari neurodegenerative e formulazioni comprendenti nanostrutture per la sua veicolazione 118
Synthesis and characterisation of novel chemical conjugates based on alpha, beta-polyaspartylhydrazide and beta-cyclodextrins 116
Kinetic studies of the interaction between DNA and polycations based on polyaspartylhydrazide 116
APPLICATION OF POLYMERIC NANOPARTICLES IN IMMUNOTHERAPY 116
BIOCOMPATIBLE POLYMERIC MICELLES WITH POLYSORBATE 80 FOR BRAIN TARGETING 114
Kinetic studies of the interaction between DNA and polycations based on polyasparthylhydrazide 114
MULTICOMPONENT POLYMERIC MICELLES BASED ON POLYASPARTAMIDE AS TUNABLE FLUORESCENT pH-WINDOW BIOSENSORS 110
Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis 110
New Amphiphilic Conjugates of Mono- and Bis(carboxy)-PEG2,000 Polymers with Lipoamino Acids as Surface Modifiers of Colloidal Drug Carriers 109
CURCUMIN ENTRAPPED INTO LIPID NANOSYSTEMS IMPROVES INHIBITION OF NEUROBLASTOMA CANCER CELL GROWTH ACTIVATING HSP70 PROTEIN 109
Combining inulin multifunctional polycation and magnetic nanoparticles: redox-responsive siRNA-loaded systems for magnetofection 109
Design of New Polyaspartamide Copolymers for siRNA Delivery in Antiasthmatic Therapy 109
SINTESI E CARATTERIZZAZIONE DI UN NUOVO DERIVATO DEL PHEA PER IL DIREZIONAMENTO ATTIVO DI FARMACI AL SISTEMA NERVOSO CENTRALE (SNC) 107
EVALUATION OF BIODEGRADABILITY ON POLYSPARTAMIDE-POLYLACTIC ACID BASED NANOPARTICLES BY CHEMICAL HYDROLYSIS STUDIES POLYMER DEGRADATION AND STABILITY 107
Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis 106
NOVEL COMPOSED GALACTOSYLATED NANODEVICES CONTAINING A RIBAVIRIN PRODRUG AS HEPATIC CELL-TARGETED CARRIERS FOR HCV TREATMENT 104
SOLID LIPID NANOPARTICLES FOR APPLICATIONS IN GENE THERAPY: A REVIEW OF THE STATE OF THE ART 102
THERAPEUTIC-LOADED LIPID NANOSTRUCTURES AND BRAIN DISEASES. 102
Improvements in Rational Design Strategies of Inulin Derivative Polycation for siRNA Delivery 101
Biomedical applications of polylactide (PLA) and its copolymers 101
Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice. 100
LIPID AND POLYMERIC NANOSTRUCTURES FOR BRAIN DRUG DELIVERY AND TARGETING 96
POLYASPARTAMIDE-G-POLYLACTIDE GRAFT COPOLYMERS ABLE TO FORM NANOPARTICLES OBTAINED BY A NOVEL SYNTHETIC STRATEGY 96
GALACTOSE-DECORATED POLYMERIC CARRIERS FOR HEPATOCYTE-SELECTIVE DRUG TARGETING 96
NANOPARTICELLE POLIMERICHE OTTENUTE DA NUOVI COPOLIMERI DI UNA POLIASPARTAMIDE 91
INULIN DERIVATIVE CROSSLINKED WITH tri-THIO: NEW pH-SENSITIVE AND BIODEGRADABILE HYDROGELS 90
EVALUATION OF THE INTERACTION AND DRUG RELEASE FROM ALPHA,BETA–POLYASPARTAMIDE DERIVATIVES TO A BIOMEMBRANE MODEL 90
NANOCOMPLEXES FOR GENE THERAPY OF RESPIRATORY DISEASES: TARGETING AND OVERCOMING THE MUCUS BARRIER 90
Influence of functionalization on interaction and drug release from alpha,beta-polyaspartylhydrazide derivatives to a biomembrane model: evaluation by differential scanning calorimetry technique 90
CURCUMIN-LOADED LIPID NANOSTRUCTURES AS DRUG DELIVERY SYSTEMS. 89
NANOSTRUCTURED LIPID CARRIERS CONTAINING RILUZOLE AND PHARMACEUTICAL FORMULATIONS CONTAINING SAID PARTICLES 89
NOVEL AMPHIPHILIC COPOLYMERS BASED ON POLYASPARTAMIDE GRAFT WITH SQUALENE RESIDUES TO OBTAIN MICELLES AS COLLOIDAL DRUG CARRIERS. 89
COMPOSITE NANOPARTICLES FOR I.V. DRUG ADMINISTRATION 88
NANOTECHNOLOGIES FOR BIOMEDICAL APLICATIONS 88
NANOSTRUCTURED LIPID CARRIER (NLC) CONTAINING FERULIC ACID: PREPARATION, CARACTERIZATION AND CYTOTOXICITY STUDIES 87
NANOPARTICLES OBTAINED FROM HYALURONIC ACID AND POLYASPARTYLHYDRAZIDE 85
A NANOPARTICULATE DRUG-DELIVERY SYSTEM FOR RIVASTIGMINE: PHYSICO-CHEMICAL AND IN VITRO BIOLOGICAL CHARACTERIZATION 85
Production of polymeric micro- and nanostructures with tunable properties as pharmaceutical delivery systems 85
EFFECTS OF KIND AND AMOUNT OF SURFACTANTS ON PHYSICAL-CHEMICAL PROPERTIES OF CATIONIC SOLID LIPID NANOPARTICLES (SLN) FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA 84
SOLID LIPID NANOPARTICLES (SLNs) CONTAINING FERULIC ACID AGAINST OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES 83
FERULIC ACID LOADED SOLID LIPID NANOPARTICLES PROTECTS LAN5 NEUROBLASTOMA CELL LINE BY Ab-AMYLOID OXIDATIVE STRESS 83
POLYMERIC MICELLES FOR DRUG TARGETING TO THE BRAIN 82
SISTEMI NANOSTRUTTURATI PER IL RILASCIO DI FARMACI AL SISTEMA NERVOSO CENTRALE 82
ENTRAPMENT OF TYRPHOSTIN AG 14-78 INTO LIPID NANOPARTICLES IMPROVES ITS ANTITUMOR ACTIVITY AGAINST HUMAN HEPATOCARCINOMA CELLS 82
NANOPARTICLES CONTAINING RIVASTIGMINE FOR THE TREATMENT OF ALZHEIMER DISEASE 81
Polymer-based systems for controlled release and targeting of drugs 81
Effect of composition of Solid Lipid Nanoparticles on their chemical-physical properties and potential for gene therapy 80
CATIONIC SOLID-LIPID NANOPARTICLES AS DNA CARRIERS 79
VETTORI NANOPARTICELLARI LIPIDICI CONTENENTI RILUZOLO E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO 78
ALTERNATIVE MATERIALS FOR PROTECTING CU- AND AG-BASED ARCHAEOLOGICAL ARTEFACTS 76
ENCAPSULATION OF SORAFENIB INTO LIPID NANOPARTICLES IMPROVES ITS ANTITUMOR ACTIVITY 75
Novel dual-flow perfusion bioreactor for in vitro pre-screening of nanoparticles delivery: design, characterization and testing 75
CHEMICALLY CROSSLINKED HYALURONAN AND alpha,beta-POLYASPARTYLHYDRAZIDE AS NANO-COMPOSITE PARTICLES 74
Totale 11.652
Categoria #
all - tutte 60.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.666 89 167 116 142 153 59 145 91 186 130 200 188
2021/20221.627 67 427 40 47 67 34 67 72 176 184 109 337
2022/20231.850 207 310 49 146 223 340 112 136 198 13 100 16
2023/20241.045 45 160 41 117 75 291 110 61 7 8 26 104
2024/20252.468 77 107 98 181 48 204 182 175 185 252 341 618
2025/2026127 127 0 0 0 0 0 0 0 0 0 0 0
Totale 15.561